← Russell 3000 cross-section

ULS UL Solutions Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-04, not restated
Healthcare

Scale

Market cap
$14.9bn
Revenue TTM
$3.1bn
Net income TTM
$505m
Free cash flow
$436m
Composite score
56.7
Sector rank
#536

Valuation

P / E
29.6
EV / EBITDA
19.7
EV / sales
4.7
FCF yield
2.92%
Earnings yield vs 10-yr
-1.35pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
16.1%
EBITDA margin
23.9%
ROE
31.7%
ROIC
38.4%
Revenue growth
6.6%

Insider activity, last 90 days

Net open-market
$-6.10m
Buyers
0
Sellers
4

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Cost of Revenue Cost of revenue includes employee compensation consisting of salaries, incentives, stock-based compensation and other benefits for employees directly attributable to revenue generation across each of the Company’s four major service categories. Three Months Ended June 30, 2026 Compared to Three Months Ended June 30, 2025 Revenue Revenue increased by $40 million, or 5.2%, for the three months ended June 30, 2026, as compared to the same period in 2025. …UL Solutions Inc., 10-Q, period ended 2026-06-30, filed 2026-08-04

Read the full passage →